Overview
Recurrent aphthous stomatitis, commonly known as recurrent mouth ulcers, is a prevalent condition affecting approximately 20% of the population 1. These ulcers are characterized by recurrent painful lesions in the oral mucosa, often causing significant discomfort and impacting quality of life. The pathophysiology of recurrent mouth ulcers involves complex interactions between inflammation, oxidative stress, and potential systemic factors. Recent studies have highlighted the role of sleep quality, particularly insomnia, in increasing the risk of developing these ulcers, likely through mechanisms involving stress, inflammation, and oxidative stress [PMID:37833753]. Additionally, bacterial infections and persistent inflammatory responses are critical barriers to healing, underscoring the need for multifaceted therapeutic approaches that address these underlying issues [PMID:39849823].
Pathophysiology
Recurrent mouth ulcers are multifactorial in nature, with several key pathophysiological mechanisms contributing to their development and persistence. One notable factor is the association between poor sleep quality and insomnia with an increased risk of mouth ulcers [PMID:37833753]. This association may be mediated by heightened stress levels, which can exacerbate inflammatory responses and increase oxidative stress, both of which are detrimental to mucosal healing. Chronic inflammation and elevated reactive oxygen species (ROS) levels are central to the impaired healing process of oral ulcers [PMID:39849823]. Bacterial infections further complicate the healing process by perpetuating an inflammatory environment that hinders tissue repair [PMID:31463739]. These findings suggest that therapeutic strategies aimed at reducing inflammation, managing oxidative stress, and controlling bacterial load could significantly improve outcomes for patients with recurrent mouth ulcers.
Epidemiology
Recurrent mouth ulcers exhibit a broad prevalence, affecting a substantial portion of the population—around 20% 1. Epidemiological studies have identified several modifiable risk factors that influence the incidence of these ulcers. Poor sleep quality and insomnia emerge as significant risk factors, with individuals experiencing insomnia showing a higher likelihood of developing mouth ulcers [PMID:37833753]. Interestingly, longer sleep durations correlate with a reduced risk of ulcer occurrence, indicating that sleep duration might be a modifiable factor in prevention strategies [PMID:37833753]. These insights highlight the importance of assessing and addressing sleep patterns in clinical practice, particularly for patients with recurrent oral ulcers. Additionally, while the exact prevalence varies, the condition can occur in both healthy individuals and those with underlying systemic diseases, emphasizing the need for a thorough clinical evaluation to rule out systemic causes [PMID:29029650].
Clinical Presentation
Recurrent mouth ulcers present with a spectrum of clinical manifestations, ranging from small, shallow lesions to larger, deeper ulcers. These ulcers typically appear as round or oval sores with erythematous haloes and yellow or gray necrotic centers [PMID:29029650]. The variability in presentation underscores the complexity of the condition, which can affect both healthy individuals and those with systemic diseases. Persistent inflammation and oxidative stress contribute to the challenges in healing, often leading to prolonged ulcer duration and recurrent episodes [PMID:39849823]. Clinically, patients frequently report pain, which can significantly impact eating, speaking, and overall quality of life. Treatment approaches that modulate inflammation and oxidative stress, such as vitamin B supplementation, have shown promise in reducing healing times and improving symptoms [PMID:34154361]. For instance, vitamin B therapy has been associated with significantly shorter healing times and lower recurrence rates, making it a valuable adjunctive treatment option [PMID:34154361].
Diagnosis
Diagnosing recurrent mouth ulcers involves a comprehensive clinical assessment to differentiate between benign aphthous stomatitis and ulcers caused by systemic conditions. Key to this process is a detailed patient history, including dietary habits, stress levels, and sleep patterns, which can provide clues to underlying triggers [PMID:29029650]. Physical examination focuses on the characteristics of the ulcers, such as their size, location, and pattern of recurrence. Laboratory tests are generally not required for typical cases but may be necessary to rule out systemic diseases like Behçet's disease, celiac disease, or HIV infection [PMID:29029650]. In specific cases, such as suspected toxic reactions to topical medications, assessing not only serum levels but also metabolite levels is crucial, as highlighted by a case report where toxic symptoms persisted despite serum lidocaine levels being within normal ranges [PMID:12547053]. This underscores the importance of a thorough evaluation beyond just direct drug levels.
Differential Diagnosis
When evaluating recurrent mouth ulcers, clinicians must consider a range of differential diagnoses to ensure appropriate management. Beyond benign aphthous stomatitis, systemic conditions such as Behçet's disease, inflammatory bowel disease, and nutritional deficiencies (e.g., iron, vitamin B12) can present with similar oral ulcerations [PMID:29029650]. Additionally, the association between insomnia and increased risk of mouth ulcers suggests that sleep disorders should be evaluated in patients with recurrent ulcers [PMID:37833753]. Clinicians should inquire about sleep quality, duration, and any symptoms of sleep apnea or other sleep disturbances. Furthermore, infectious causes, such as herpetic stomatitis or candidiasis, should be ruled out through appropriate clinical assessment and, if necessary, laboratory tests. This comprehensive approach ensures that underlying systemic causes are not overlooked, guiding appropriate referral to specialists when needed.
Management
The management of recurrent mouth ulcers aims to alleviate symptoms, promote healing, and prevent recurrence. Enhancing sleep quality and addressing sleep disorders, given their association with increased ulcer risk, should be a foundational aspect of management strategies [PMID:37833753]. Non-pharmacological interventions include stress reduction techniques, maintaining good oral hygiene, and avoiding known triggers such as spicy or acidic foods. Pharmacological treatments often target inflammation and oxidative stress. Vitamin B supplementation has demonstrated significant benefits, with meta-analyses showing higher effective rates and lower recurrence rates compared to controls [PMID:34154361]. Additionally, innovative therapeutic approaches like drug-loaded nanofibrous meshes incorporating curcumin and mucoadhesive properties have shown promise in preclinical studies by providing sustained release of anti-inflammatory and antiseptic agents, sequentially addressing bacterial infection, inflammation, and promoting tissue regeneration [PMID:31334627]. MH/OPC-HP microneedle patches have also shown efficacy in reducing oxidative stress, inflammation, and promoting healing in animal models [PMID:39849823]. These advancements suggest potential for improved clinical outcomes when integrated into treatment protocols. Dental practitioners should consider these newer modalities while also adhering to established guidelines for when to refer patients with complex or systemic underlying causes to secondary care [PMID:29029650].
Complications
While recurrent mouth ulcers are generally benign, complications can arise, particularly with improper use of topical treatments. A notable complication highlighted in a case report involves excessive use of viscous lidocaine, where toxic symptoms persisted despite serum levels being within normal ranges, indicating potential contributions from lidocaine metabolites [PMID:12547053]. Clinicians must monitor not only the direct drug levels but also metabolites to prevent such adverse effects. Additionally, chronic ulcers can lead to scarring, altered taste perception, and significant functional impairment, impacting a patient's ability to eat and speak comfortably. Ensuring proper management and timely intervention can mitigate these risks and improve overall patient outcomes.
Prognosis & Follow-up
The prognosis for recurrent mouth ulcers varies widely depending on the underlying causes and the effectiveness of management strategies. Preclinical studies using innovative treatments like MH/OPC-HP microneedle patches have shown promising results, with significant acceleration in ulcer healing and reduced inflammation, suggesting improved long-term outcomes [PMID:39849823]. Meta-analyses further support this optimism, indicating a substantially lower recurrence rate in patients treated with vitamin B compared to controls, which translates to better long-term management and reduced need for frequent interventions [PMID:34154361]. Regular follow-up is essential to monitor healing progress, adjust treatments as necessary, and address any emerging complications. Clinicians should maintain a vigilant approach, particularly in patients with systemic risk factors, ensuring that any recurrence or new symptoms are promptly evaluated and managed.
Key Recommendations
These recommendations aim to provide a comprehensive approach to managing recurrent mouth ulcers, integrating both traditional and emerging therapeutic strategies to improve patient outcomes.
References
1 Liu Q, Wang J, Liu T, Zeng X, Zhang X. Identification of the causal relationship between sleep quality, insomnia, and oral ulcers. BMC oral health 2023. link 2 Wei L, Wu S, Shi W, Aldrich AL, Kielian T, Carlson MA et al.. Large-Scale and Rapid Preparation of Nanofibrous Meshes and Their Application for Drug-Loaded Multilayer Mucoadhesive Patch Fabrication for Mouth Ulcer Treatment. ACS applied materials & interfaces 2019. link 3 Zhang X, Zhong G, Peng S, Zhang C, Li B, Xia Z et al.. Reactive Oxygen Species-Responsive Gel-Based Microneedle Patches with Antimicrobial and Immunomodulating Properties for Oral Mucosa Disease Treatment. ACS biomaterials science & engineering 2025. link 4 Shi J, Wang L, Zhang Y, Zhi D. Clinical efficacy of vitamin B in the treatment of mouth ulcer: a systematic review and meta-analysis. Annals of palliative medicine 2021. link 5 Gu Y, Huang Y, Qiu Z, Xu Z, Li D, Chen L et al.. Vitamin B. Science China. Life sciences 2020. link 6 Thakrar P, Chaudhry SI. Oral Ulceration: An Overview of Diagnosis and Management. Primary dental journal 2016. link 7 Singh K, Chand P, Singh BP, Patel CB. Study of the effect of surface treatment on the long term effectiveness of tissue conditioner. Journal of oral science 2010. link 8 Yamashita S, Sato S, Kakiuchi Y, Miyabe M, Yamaguchi H. Lidocaine toxicity during frequent viscous lidocaine use for painful tongue ulcer. Journal of pain and symptom management 2002. link00498-0)